title: Outcomes following pneumococcal meningitis: room for improvement remains expansive.
authors.forename: Bryan A
authors.initials: BA
authors.lastname: Fisk
authors.forename: William L
authors.initials: WL
authors.lastname: Jackson
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage*; D019983:Guideline Adherence; D006801:Humans; D007362:Intensive Care Units; D008586:Meningitis, Pneumococcal / Q000188:drug therapy* / Q000401:mortality; D013997:Time Factors; D018440:beta-Lactam Resistance
chemical_list: D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D003907:Dexamethasone